Lethal ex­per­i­men­tal can­cer drug from Han­mi, Boehringer killed three pa­tients — re­port

Ko­re­an health of­fi­cials have tied the deaths of three pa­tients to a can­cer drug launched by Han­mi Phar­ma­ceu­ti­cals and part­nered with Boehringer In­gel­heim, ac­cord­ing to a fol­lowup sto­ry in The Ko­rea Her­ald.

Cit­ing a re­port from the coun­try’s Min­istry of Food and Drug Safe­ty, which was re­leased by Rep. Kwon Mi-hyuk to­day, the three were a 75-year-old pa­tient who died in late 2015, a 57-year-old who died in March and a 54-year-old who died in June.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER